International Collaboration Launches Innovative Projects to Enhance Cancer Detection Technologies

The Center for Innovation and Translation of Point of Care Technologies for Equitable Cancer Care (CITEC), led by Rice University, has made significant strides toward improving global cancer care by announcing its inaugural group of subawardees. This milestone is particularly vital for the advancement of cancer detection and treatment technologies, especially in regions with limited resources, where healthcare disparities often yield dire consequences. CITEC’s mission aligns with the pressing need for innovative health solutions that address the unique challenges faced by underserved populations around the globe.

CITEC is not working alone in its efforts; it has created a collaborative network that spans three continents and integrates seven leading organizations. Its members include esteemed institutions such as the Rice360 Institute for Global Health Technologies, the Baylor College of Medicine, and the University of Texas MD Anderson Cancer Center. This consortium aims to leverage expertise across various disciplines, ensuring that the solutions developed will be both practical and impactful in real-world settings.

Underpinned by a generous five-year grant from the National Institutes of Health (NIH), CITEC is ideally positioned to emerge as a premier research center within the Texas Medical Center. This funding aims to facilitate the transformative potential of research projects that explore novel approaches to cancer care, particularly those designed to improve accessibility and affordability. As a pivotal component of its mission, CITEC actively supports groundbreaking research through subgrants, targeting initiatives that resonate with its overarching goals of equitable healthcare.

Earlier this year, CITEC launched a solicitation for subgrants, vigorously reviewing submissions from researchers dedicated to making a difference in cancer prevention and treatment. From a pool of competitive applications, four exceptional inaugural subawardees were selected to embark on their innovative projects. Each of these projects exemplifies CITEC’s commitment to fostering ingenuity and advancing health equity.

Sanchita Bhadra, a research assistant professor at the University of Texas at Austin, has been awarded a subgrant for her project focused on developing an affordable, single-visit test for the detection of 14 high-risk HPV types—a significant contributor to cervical cancer. By implementing a color-change indicator for ease of interpretation, Bhadra’s project seeks to refine HPV screening processes. This endeavor is poised to not only lower costs but also reduce the need for multiple follow-up visits, making cancer screening more approachable for women in low-resource settings.

Dongkyun Kang, an assistant professor of optical sciences and biomedical engineering at the University of Arizona, has been recognized for his innovative work in creating deep learning algorithms that analyze images from sLSM (super-resolution light-sheet mapping) imaging techniques. This technology aims to assist physicians in biopsy decision-making for anal lesions. The potential to achieve a sensitivity of 91 percent and specificity of 85 percent in lesion detection positions Kang’s work at the forefront of clinical innovation, ultimately enhancing patient outcomes in diverse healthcare settings.

Dr. Daniel Rosen, a professor of pathology and immunology at Baylor College of Medicine, is focused on developing an affordable, 3D-printed microscope known as the OpenFlexure Microscope. This revolutionary tool is designed for use in low- and middle-income countries, particularly for cancer screening endeavors. The project’s emphasis on telepathology underscores the increasing need for remote diagnostics in regions where medical resources may be scarce. Rosen’s initiative includes not only clinical validation but also essential staff training to ensure sustainability and accessibility in cancer screening.

Nancy Schoenbrunner, CEO of AmplifiDx, is leading a pivotal project aimed at enhancing HPV testing methodologies. By integrating E6/E7 mRNA detection within the DX-100 system, Schoenbrunner’s research seeks to expedite the triage process for women at risk of cervical cancer. This research could provide a faster and more accurate assessment compared to traditional DNA-based tests, facilitating timely interventions that could significantly alter cancer prognosis for at-risk populations.

The selection of these subawardees reflects a strategic commitment to nurturing innovation and addressing critical gaps in cancer detection and treatment. Each initiative not only draws attention to pressing health issues but also encompasses the potential for transformative change within communities that are often overlooked by conventional healthcare models. As disease patterns evolve and the need for tailored healthcare solutions intensifies, the work of these researchers could represent a turning point in how we approach global cancer care.

Dr. Sharmila Anandasabapathy, a key figure in CITEC, emphasizes the importance of these projects in bridging health equity gaps. She observes that these innovative initiatives not only advance health technology but also embody the very principles of accessibility and fairness in healthcare delivery. The potential of each project to yield tangible, positive outcomes for underserved communities resonates with CITEC’s foundational goals and mission.

CITEC’s funding under the Point-of-Care Technologies Research Network offers a comprehensive framework for ensuring that these innovations are not only developed but also implemented effectively in real-world settings. This approach highlights the vital relationship between research funding and practical application, reminding us that the journey from laboratory discovery to patient bedside is a complex yet rewarding path.

In conclusion, the CITEC initiative stands as a beacon of hope in the ongoing battle against cancer. By fostering collaboration among leading institutions and supporting pioneering research, CITEC is not only tackling the immediate needs of cancer detection and treatment but is also laying the groundwork for long-lasting change in global health equity. The collective efforts of these awardees illustrate a paradigm shift toward more inclusive healthcare solutions, reminding us that innovation thrives at the intersection of compassion and science.

As the world continues to confront the multifaceted challenges of cancer care, the dedication demonstrated by CITEC and its inaugural subawardees offers a roadmap for future advancements. Together, they are not simply addressing cancer; they are reshaping how we think about health equality, access, and the transformative power of technology in medicine.

—

News Publication Date: October 2023

Web References: https://rice360.rice.edu/citec; https://openbioeconomy.org/people/dr-sanchita-bhadra/; https://bme.engineering.arizona.edu/faculty-staff/faculty/dongkyun-kang; https://www.bcm.edu/people-search/daniel-rosen-29805; https://www.amplifidx.com/; https://www.bcm.edu/people-search/sharmila-anandasabapathy-17390; https://secure-web.cisco.com/1hHIW4dU0iO16EHB_5508N5Fao0XOK8WKmupNBdE_YB-EWfIFnfXL5LPNh42meXhq-fzlzPJ8hCIbixQTBSgawPPs4F8SMas9d9qRdhdtRDIMv9RkAFy0JT67ymvQij_vhFnOb_F3X4xP3GseWg8Kk6GNbckd96UeZKCxU607C_-7V1chgw9hIgTUJMx06Nepf_DP3_gq4HEex7-f1jYVommekCaFOJYfkRQ1QL3EETif8vvxH4FVCc3wfyP8NLwGBxHzsHuC_pLofZxo4FniqyG9KObJ84dH7k8Su3mxve-xrynSe_8YsN2gqQO2viK9qBGFNXIjYWKUodcc4yeQWg/https%3A%2F%2Fwww.nibib.nih.gov%2Fprograms%2Fpoint-care-technologies-research-network

References: National Institutes of Health funding, CITEC initiative details